Home LiteratureArticle Details
PMID: 3479440 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Dietary fat clearance in normal subjects is regulated by genetic variation in apolipoprotein E.

The Journal of clinical investigation ·Vol. 80 ·No. 6 ·1987-12-00 ·Pages 1571-7

Weintraub MS, Eisenberg S, Breslow JL

Abstract

Apolipoprotein E (apo E) plays an important role in receptor mediated clearance of lipoprotein particles from plasma. Common genetic variation in apo E exists with three alleles coding for proteins called E2, E3, and E4. In in vitro receptor binding assays, E2 binds poorly, whereas E3 and E4 function normally. Recently, the apo E phenotype has been shown to have an effect on low density lipoprotein (LDL) cholesterol levels with levels in subjects with E2 lower and E4 higher than E3. We have examined the effect of the apo E polymorphism on dietary fat clearance using the vitamin A-fat loading test, which specifically labels intestinally derived lipoproteins with retinyl palmitate (RP). 27 normal subjects were studied, 10 with E3/3, 9 with E3/2, 7 with E4/3, and 1 with E4/4. After a vitamin A-containing fatty meal, postprandial RP concentrations were measured in chylomicron (Sf greater than 1,000) and nonchylomicron (Sf less than 1,000) fractions for 14 h. Compared with E3/3 subjects, E3/2 subjects had a significantly higher nonchylomicron RP concentration (P less than 0.05) (peak heights and areas below the curves) indicating slower clearance and the E4/3, E4/4 group had a significantly lower nonchylomicron RP concentration (P less than 0.05) indicating faster clearance. The clearance in the latter group was twice that of E3/2 subjects (P less than 0.01). Thus, heterozygosity for the defective form of apo E, E2, delays, and the surprising presence of a functionally normal allele, E4, increases clearance. This apo E effect on exogenous fat clearance may explain the recently described effect of the apo E phenotypes on LDL cholesterol levels.

MeSH Terms
Adult Aged Apolipoproteins E/genetics Cholesterol/blood Cholesterol, HDL/blood Cholesterol, LDL/blood Cholesterol, VLDL Chylomicrons/metabolism Dietary Fats/metabolism Diterpenes Female Genetic Variation Humans Lipoproteins, VLDL/blood Male Middle Aged Phenotype Retinyl Esters Vitamin A/analogs & derivatives
Chemicals
Apolipoproteins E Cholesterol, HDL Cholesterol, LDL Cholesterol, VLDL Chylomicrons Dietary Fats Diterpenes Lipoproteins, VLDL Retinyl Esters Vitamin A retinol palmitate Cholesterol
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Weintraub M S
Laboratory of Biochemical Genetics and Metabolism, Rockefeller University, New York, New York 10021.
Eisenberg S
Breslow J L
References (51)
51 references, click to expand
  1. Heterogeneity of human plasma very low density lipoproteins. Separation of species differing in protein components.
    Biochemistry. 1973 Jan 30;12(3):502-7 PMID: 4345806
  2. Simultaneous determination of retinol and retinyl esters in serum or plasma by reversed-phase high-performance liquid chromatography.
    Clin Chem. 1978 Nov;24(11):1920-3 PMID: 709821
  3. Delayed clearance of chylomicron remnants following vitamin-A-containing oral fat loads in broad-beta disease (type III hyperlipoproteinemia).
    Metabolism. 1976 JUL;25(7):777-801 PMID: 181657
  4. Chylomicron clearance in normal and hyperlipidemic man.
    Metabolism. 1976 Nov;25(11):1225-39 PMID: 185486
  5. HDL cholesterol and other lipids in coronary heart disease. The cooperative lipoprotein phenotyping study.
    Circulation. 1977 May;55(5):767-72 PMID: 191215
  6. Polymorphism of apolipoprotein E. II. Genetics of hyperlipoproteinemia type III.
    Clin Genet. 1979 Jan;15(1):37-62 PMID: 215360
  7. Polymorphism of apolipoprotein E. III. Effect of a single polymorphic gene locus on plasma lipid levels in man.
    Clin Genet. 1979 Jan;15(1):63-72 PMID: 759055
  8. Human intestinal lipoproteins. Studies in chyluric subjects.
    J Clin Invest. 1979 Jul;64(1):233-42 PMID: 221544
  9. Rapid hepatic clearance of the canine lipoproteins containing only the E apoprotein by a high affinity receptor. Identity with the chylomicron remnant transport process.
    J Biol Chem. 1980 Mar 10;255(5):1804-7 PMID: 7354059
  10. Effect of apoproteins on hepatic uptake of triglyceride emulsions in the rat.
    J Clin Invest. 1980 Mar;65(3):652-8 PMID: 7354132
  11. Membrane changes associated with platelet activation. Exposure of actin on the platelet surface after thrombin-induced secretion.
    J Clin Invest. 1980 Jul;66(1):1-9 PMID: 6772667
  12. Regulation of the hepatic uptake of triglyceride-rich lipoproteins in the rat. Opposing effects of homologous apolipoprotein E and individual C apoproteins.
    J Biol Chem. 1980 Sep 10;255(17):8303-7 PMID: 7410365
  13. Prevalence of coronary heart disease in the Framingham Offspring Study: role of lipoprotein cholesterols.
    Am J Cardiol. 1980 Oct;46(4):649-54 PMID: 7416024
  14. Radioimmunoassay of human arginine-rich apolipoprotein, apoprotein E. Concentration in blood plasma and lipoproteins as affected by apoprotein E-3 deficiency.
    J Clin Invest. 1980 Dec;66(6):1351-62 PMID: 7440719
  15. Human apolipoprotein E isoprotein subclasses are genetically determined.
    Am J Hum Genet. 1981 Jan;33(1):11-24 PMID: 7468588
  16. Human very low density lipoprotein apolipoprotein E isoprotein polymorphism is explained by genetic variation and posttranslational modification.
    Biochemistry. 1981 Feb 17;20(4):1033-41 PMID: 6260135
  17. Lipoprotein binding to canine hepatic membranes. Metabolically distinct apo-E and apo-B,E receptors.
    J Biol Chem. 1981 Jun 10;256(11):5646-55 PMID: 6263887
  18. Two independent lipoprotein receptors on hepatic membranes of dog, swine, and man. Apo-B,E and apo-E receptors.
    J Clin Invest. 1981 Nov;68(5):1197-206 PMID: 6271808
  19. Human apolipoprotein E. The complete amino acid sequence.
    J Biol Chem. 1982 Apr 25;257(8):4171-8 PMID: 7068630
  20. Dextran sulfate-Mg2+ precipitation procedure for quantitation of high-density-lipoprotein cholesterol.
    Clin Chem. 1982 Jun;28(6):1379-88 PMID: 7074948
  21. Structural and metabolic heterogeneity of beta-very low density lipoproteins from cholesterol-fed dogs and from humans with type III hyperlipoproteinemia.
    J Lipid Res. 1982 Jul;23(5):702-14 PMID: 7119569
  22. Proposed nomenclature of apoE isoproteins, apoE genotypes, and phenotypes.
    J Lipid Res. 1982 Aug;23(6):911-4 PMID: 7130859
  23. Genetic variation in human apolipoprotein E.
    J Lipid Res. 1982 Nov;23(8):1174-82 PMID: 7175374
  24. Dynamics of apolipoprotein E metabolism in humans.
    J Lipid Res. 1982 Dec;23(9):1308-16 PMID: 7161560
  25. Plasma lipoprotein retinoids after vitamin A feeding in normal man: minimal appearance of retinyl esters among low-density lipoproteins.
    Metabolism. 1983 May;32(5):514-7 PMID: 6682471
  26. Lipoprotein receptors and cholesterol homeostasis.
    Biochim Biophys Acta. 1983 May 24;737(2):197-222 PMID: 6303423
  27. Apolipoprotein E polymorphism and coronary artery disease.
    Arteriosclerosis. 1983 Jul-Aug;3(4):310-5 PMID: 6882285
  28. The receptor-binding domain of human apolipoprotein E. Binding of apolipoprotein E fragments.
    J Biol Chem. 1983 Oct 25;258(20):12341-7 PMID: 6313652
  29. The receptor-binding domain of human apolipoprotein E. Monoclonal antibody inhibition of binding.
    J Biol Chem. 1983 Oct 25;258(20):12348-54 PMID: 6313653
  30. Apolipoprotein E phenotypes and hyperlipidemia.
    Hum Genet. 1984;65(3):232-6 PMID: 6698547
  31. Type III hyperlipoproteinemia: recent insights into the genetic defect of familial dysbetalipoproteinemia.
    Adv Intern Med. 1984;29:385-411 PMID: 6369930
  32. Apolipoprotein E polymorphism and hyperlipidemia.
    Clin Chem. 1984 May;30(5):641-3 PMID: 6713624
  33. Polymorphism at the apoprotein-E locus in relation to risk of coronary disease.
    Clin Genet. 1984 Apr;25(4):310-3 PMID: 6713705
  34. Normalization of receptor binding of apolipoprotein E2. Evidence for modulation of the binding site conformation.
    J Biol Chem. 1984 Jun 10;259(11):7261-7 PMID: 6327714
  35. Plasma clearance of chylomicrons labeled with retinyl palmitate in healthy human subjects.
    J Lipid Res. 1984 Aug;25(8):805-12 PMID: 6491526
  36. Role of the apolipoprotein E polymorphism in determining normal plasma lipid and lipoprotein variation.
    Am J Hum Genet. 1985 Mar;37(2):268-85 PMID: 3985008
  37. Characterization of very low density lipoproteins and intermediate density lipoproteins of normo- and hyperlipidemic apolipoprotein E-2 homozygotes.
    J Lipid Res. 1985 Mar;26(3):316-26 PMID: 3989390
  38. Effects of apoprotein E polymorphism on serum lipoprotein concentration.
    Arteriosclerosis. 1985 May-Jun;5(3):283-92 PMID: 3857910
  39. Postchallenge plasma lipoprotein retinoids: chylomicron remnants in endogenous hypertriglyceridemia.
    Metabolism. 1985 Jun;34(6):551-8 PMID: 3999977
  40. Plasma decay of chylomicron remnants is not affected by heparin-stimulated plasma lipolytic activity in normal fasting man.
    J Lipid Res. 1985 Jul;26(7):852-9 PMID: 4031663
  41. Hepatic retinol metabolism. Distribution of retinoids, enzymes, and binding proteins in isolated rat liver cells.
    J Biol Chem. 1985 Nov 5;260(25):13560-5 PMID: 2997171
  42. Apolipoprotein E polymorphism in the Finnish population: gene frequencies and relation to lipoprotein concentrations.
    J Lipid Res. 1986 Mar;27(3):227-35 PMID: 3734624
  43. Abnormal in vivo metabolism of apolipoprotein E4 in humans.
    J Clin Invest. 1986 Sep;78(3):815-21 PMID: 3745440
  44. Contraceptive steroids increase hepatic uptake of chylomicron remnants in healthy young women.
    J Lipid Res. 1986 Jun;27(6):645-51 PMID: 3746133
  45. Different patterns of postprandial lipoprotein metabolism in normal, type IIa, type III, and type IV hyperlipoproteinemic individuals. Effects of treatment with cholestyramine and gemfibrozil.
    J Clin Invest. 1987 Apr;79(4):1110-9 PMID: 3470306
  46. Kinetics of chylomicron remnant clearance in normal and in hyperlipoproteinemic subjects.
    J Lipid Res. 1987 Feb;28(2):195-206 PMID: 3572247
  47. Particulate fat in lymph and blood.
    Physiol Rev. 1962 Oct;42:674-701 PMID: 14028424
  48. Polymorphism of apolipoprotein E and occurrence of dysbetalipoproteinaemia in man.
    Nature. 1977 Oct 13;269(5629):604-7 PMID: 199847
  49. Apoprotein (E--A-II) complex of human plasma lipoproteins. I. Characterization of this mixed disulfide and its identification in a high density lipoprotein subfraction.
    J Biol Chem. 1978 Sep 10;253(17):6281-8 PMID: 210174
  50. Composition of proteins of mesenteric lymph chylomicrons in the rat and alterations produced upon exposure of chylomicrons to blood serum and serum proteins.
    J Lipid Res. 1978 Aug;19(6):712-22 PMID: 690511
  51. Selective measurement of two lipase activities in postheparin plasma from normal subjects and patients with hyperlipoproteinemia.
    J Clin Invest. 1974 Nov;54(5):1107-24 PMID: 4370795
Article Info
Journal
The Journal of clinical investigation
Abbr.
J Clin Invest
ISSN
0021-9738
Published
1987-12-00
Pages
1571-7
Language
English
Region
United States
NLM ID
7802877
PMCID
PMC442425
Subset
IM
Grants
NIA NIH HHS · AG-04727 · United States
NHLBI NIH HHS · HL-32435 · United States
NHLBI NIH HHS · HL-33714 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com